Ludmila Nieuweboer-Krobotová

Suggest Changes
Learn More
BACKGROUND Melanoma is an immunogenic tumour. The development of skin depigmentation or melanoma-associated leucoderma (MAL) has been associated with favourable clinical outcome in patients with(More)